Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.
暂无分享,去创建一个
Kedar S Vaidya | D. Wong | D. Welch | W. Korz | M. M. Richert | C. Mills | D. Hurst | Danny R Welch | Douglas R Hurst | Donald Wong | Walter Korz | Monica M Richert | Caroline N Mills
[1] S. Eccles,et al. Metastasis: recent discoveries and novel treatment strategies , 2007, The Lancet.
[2] T. Kipps,et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. , 2005, Blood.
[3] Jianhua Wang,et al. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis , 2007, Cancer and Metastasis Reviews.
[4] Hirokazu Tamamura,et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. , 2005, Blood.
[5] P. Allavena,et al. Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4 , 2004, Cancer Research.
[6] Craig Murdoch,et al. CXCR4: chemokine receptor extraordinaire , 2000, Immunological reviews.
[7] Kedar S Vaidya,et al. BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. , 2008, The American journal of pathology.
[8] David Zurakowski,et al. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. , 2006, Journal of the National Cancer Institute.
[9] V. Wee Yong,et al. CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival* , 2002, The Journal of Biological Chemistry.
[10] F. Balkwill,et al. The chemokine network in cancer--much more than directing cell movement. , 2004, The International journal of developmental biology.
[11] Takuya Akashi,et al. Chemokine receptors in cancer metastasis and cancer cell‐derived chemokines in host immune response , 2007, Cancer science.
[12] Evan T Keller,et al. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. , 2002, Cancer research.
[13] M. Ratajczak,et al. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. , 2004, Blood cells, molecules & diseases.
[14] D. Piwnica-Worms,et al. CXCR 4 Regulates Growth of Both Primary and Metastatic Breast Cancer , 2004 .
[15] T. Dittmar,et al. Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner , 2007, Clinical & Experimental Metastasis.
[16] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[17] C. Bordignon,et al. Expression of CXCR4, the receptor for stromal cell‐derived factor‐1 on fetal and adult human lymphohematopoietic progenitors , 1999, European journal of immunology.
[18] A. Sahin,et al. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow , 2005, Clinical & Experimental Metastasis.
[19] S. Nishikawa,et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 , 1996, Nature.
[20] L. Akslen,et al. Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch , 2006, Cell cycle.
[21] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[22] Geoffrey C Gurtner,et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.
[23] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[24] A. Ho,et al. The Many Facets of SDF-1α, CXCR4 Agonists and Antagonists on Hematopoietic Progenitor Cells , 2007, Journal of biomedicine & biotechnology.
[25] M. Hung,et al. Breast cancer brain metastases , 2007, Cancer and Metastasis Reviews.
[26] J. Kappes,et al. Kinetics of Metastatic Breast Cancer Cell Trafficking in Bone , 2006, Clinical Cancer Research.
[27] L. Helman,et al. Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases , 2007, Clinical & Experimental Metastasis.
[28] Xiaoqi Liu,et al. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression. , 2008, Cancer letters.
[29] A. Ben-Baruch,et al. Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor–microenvironment interactions , 2002, Breast Cancer Research.
[30] T. Springer,et al. The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood , 1997, The Journal of experimental medicine.
[31] D. Welch. Do we need to redefine a cancer metastasis and staging definitions? , 2006, Breast disease.
[32] N. Fujii,et al. Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. , 2005, Cancer research.
[33] R. Bronson,et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Shah,et al. CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro , 2005, Aging cell.